Scisparc Stock Investor Sentiment

SPRC Stock  USD 0.21  0.01  4.55%   
About 61% of Scisparc's investor base is looking to short. The analysis of the overall investor sentiment regarding Scisparc suggests that many traders are alarmed. The current market sentiment, together with Scisparc's historical and current headlines, can help investors time the market. In addition, many technical investors use Scisparc stock news signals to limit their universe of possible portfolio assets.
  

Scisparc Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Scisparc can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a year ago at news.google.com         
Jeffs Brands Notice and Proxy Statement for the Annual General Meeting to be held on September 5, 20...
Google News at Macroaxis
over a year ago at seekingalpha.com         
SciSparc to begin testing CBD-based treatment for autism in kids
seekingalpha News
over a year ago at finance.yahoo.com         
SciSparc to Commence Its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
Yahoo News
over a year ago at news.google.com         
Dr. Fatima Cody Stanford, Associate Professor of Medicine and Pediatrics at Harvard Medical School, ...
Google News at Macroaxis
over a year ago at benzinga.com         
SciSparc To Conduct Clinical Trial For Dronabinol-Based Drug To Treat Tourette Syndrome In Germany
benzinga news
over a year ago at investing.com         
SciSparc Receives Approval to Conduct Phase IIb Clinical Trial for SCI-110 to Treat Tourette Syndrom...
Investing News at Macroaxis
over a year ago at finance.yahoo.com         
EXCLUSIVE SciSparcs Tourette Syndrome Candidate Receives IRB Approval To Start Phase 2b Study In US
Yahoo News
over a year ago at benzinga.com         
EXCLUSIVE SciSparcs Tourette Syndrome Candidate Receives IRB Approval To Start Phase 2b Study In US
benzinga news
over a year ago at news.google.com         
SciSparc and Clearmind Medicine to Conduct a Study Evaluating Their Combination Treatment for Obesit...
Google News at Macroaxis
over a year ago at globenewswire.com         
SciSparc Grants an Exclusive License for the Sales of CannAmide on the Amazon Marketplace in Canada ...
Macroaxis News: globenewswire.com
over a year ago at benzinga.com         
New Drug Based On FDA-Approved Synthetic THC And CannAmide Shows Promise In Treating Agitation In Al...
benzinga news
over a year ago at news.google.com         
SciSparc Makes Another Step Towards Unlocking Potential Value Appoints New Strategy and Business Dev...
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
SciSparc Ltd. Short Interest Up 26.4 percent in April
news
over a year ago at globenewswire.com         
SciSparcs Drug Discovery Joint Venture MitoCareX Bio Successfully Developed its Core Algorithm to al...
Macroaxis News: globenewswire.com
over a year ago at investing.com         
SciSparc Completed Treatment of Last Patient Enrolled for its Phase IIa Clinical Trial for Alzheimer...
Investing News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Scisparc that are available to investors today. That information is available publicly through Scisparc media outlets and privately through word of mouth or via Scisparc internal channels. However, regardless of the origin, that massive amount of Scisparc data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Scisparc news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Scisparc relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Scisparc's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Scisparc alpha.

Scisparc Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
SciSparc extends additional loan of 1.85M to AutoMax
09/11/2024
2
SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination Therapy
09/16/2024
3
SciSparc signs LOI to sell entire ownership in MitoCareX
09/26/2024
4
National Poll on Perceptions of Mental Health and Suicide Prevention Reveals Most U.S. Adults Believe Suicide is Preventable
10/09/2024
5
SciSparc Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 - Marketscreener.com
11/04/2024

Complementary Tools for Scisparc Stock analysis

When running Scisparc's price analysis, check to measure Scisparc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scisparc is operating at the current time. Most of Scisparc's value examination focuses on studying past and present price action to predict the probability of Scisparc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scisparc's price. Additionally, you may evaluate how the addition of Scisparc to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories